Gitterman Wealth Management’s GSK GSK Stock Holding History

Gitterman Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,256	Closed	-$125K	–	213
2025 Q2	$125K	Buy	+3,256	New	+$124K	0.03%	221
2023 Q1	–	Sell	-7,529	Closed	-$265K	–	94
2022 Q4	$265K	Sell	7,529 -18	-0.2%	-$600	0.13%	42
2022 Q3	$222K	Buy	7,547 +27	+0.4%	+$1.02K	0.23%	51
2022 Q2	$407K	Sell	7,520 -183	-2%	-$10.1K	0.38%	29
2022 Q1	$420K	Buy	7,703 +3,755	+95%	+$204K	0.34%	36
2021 Q4	$218K	Buy	+3,948	New	+$205K	0.16%	78

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Gitterman Wealth Management's GSK Position: Q3 2025 in Review

Gitterman Wealth Management sold out of GSK (GSK) in Q3 2025, closing a stake of 3,256 shares — an estimated $125K sold.

Gitterman Wealth Management first reported a position in GSK in Q4 2021 and held it in 6 quarters. The position peaked at $420K in Q1 2022. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Gitterman Wealth Management reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
Gitterman Wealth Management sold 3,256 GSK shares in Q3 2025, an estimated $125K.
Gitterman Wealth Management first reported a position in GSK in Q4 2021 and held it in 6 quarters.
Gitterman Wealth Management's GSK position peaked at $420K in Q1 2022.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Gitterman Wealth Management's 13F filing for Q3 2025, filed 4 Nov 2025.